nicotine has been researched along with evp-6124 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benson, L; Dull, G; Fedorov, NB; Genus, JF; Hammond, PS; Hauser, TA; James, JW; Kombo, DC; Mazurov, AA; Miao, L; Miller, CH; Sidach, S; Xiao, Y; Yohannes, D | 1 |
| Bellucci, C; Dei, S; Kudryavtsev, D; Manetti, D; Romanelli, MN; Shelukhina, I; Spirova, E; Teodori, E; Tsetlin, V; Varani, K | 1 |
2 other study(ies) available for nicotine and evp-6124
| Article | Year |
|---|---|
Discovery of (2S,3R)-N-[2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a selective α7 nicotinic acetylcholine receptor agonist, for the treatment of cognitive disorders.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzofurans; CHO Cells; Cognition Disorders; Cricetinae; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Models, Molecular; Molecular Structure; Quinuclidines; Rats; Receptors, Nicotinic; Structure-Activity Relationship | 2012 |
New quinoline derivatives as nicotinic receptor modulators.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Bridged Bicyclo Compounds; Calcium; Cell Line, Tumor; Humans; Mice; Molecular Docking Simulation; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Quinolines; Rats; Receptors, Nicotinic; Xenopus | 2016 |